Charles Schwab Investment Management Inc 2seventy Bio, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 413,599 shares of TSVT stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

413,599

Previous 449,278 7.94%

Holding current value

$1.24 Million

Previous $1.73 Million 12.9%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.85 - $5.05 $137,364 - $180,178	-35,679 Reduced 7.94%	413,599 $1.95 Million
Q2 2024 Aug 12, 2024	SELL	$3.6 - $5.79 $594,889 - $956,780	-165,247 Reduced 26.89%	449,278 $1.73 Million
Q1 2024 May 08, 2024	SELL	$3.09 - $6.0 $14,801 - $28,740	-4,790 Reduced 0.77%	614,525 $3.29 Million
Q4 2023 Feb 06, 2024	BUY	$1.57 - $4.58 $116,828 - $340,811	74,413 Added 13.66%	619,315 $2.64 Million
Q3 2023 Nov 08, 2023	BUY	$3.14 - $11.2 $399,009 - $1.42 Million	127,073 Added 30.41%	544,902 $2.14 Million
Q2 2023 Aug 09, 2023	BUY	$8.45 - $12.48 $826,714 - $1.22 Million	97,836 Added 30.57%	417,829 $4.23 Million
Q1 2023 May 11, 2023	SELL	$9.21 - $14.98 $14,607 - $23,758	-1,586 Reduced 0.49%	319,993 $3.26 Million
Q4 2022 Feb 13, 2023	BUY	$8.57 - $17.0 $58,858 - $116,756	6,868 Added 2.18%	321,579 $3.01 Million
Q3 2022 Nov 14, 2022	BUY	$12.56 - $17.54 $576,428 - $804,980	45,894 Added 17.07%	314,711 $4.58 Million
Q2 2022 Aug 15, 2022	BUY	$10.55 - $18.81 $1.04 Million - $1.86 Million	98,686 Added 58.01%	268,817 $3.55 Million
Q1 2022 May 13, 2022	BUY	$11.67 - $26.72 $71,688 - $164,140	6,143 Added 3.75%	170,131 $2.9 Million
Q4 2021 Feb 11, 2022	BUY	$13.77 - $42.56 $2.26 Million - $6.98 Million	163,988 New	163,988 $4.2 Million

Others Institutions Holding TSVT

# of Institutions

126

Shares Held

45.6M

Call Options Held

122K

Put Options Held

19.8K

View Full List

About 2seventy bio, Inc.

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $113M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

More about TSVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc 2seventy Bio, Inc. Transaction History